Anand Nambiar appointed as MD at Merck
The drug company, Merck, appointed Anand Nambiar as its new MD in place of Dr. Claus-Dieter Boedecker who resigned from the company. Boedecker submitted his resignation to the Board of the company owing his desire to relocate to his home country, Germany. Nambiar will take over as the new MD from January 31, 2015.
The drug company, Merck, appointed Anand Nambiar as its new MD in place of Dr. Claus-Dieter Boedecker who resigned from the company. Boedecker submitted his resignation to the Board of the company owing his desire to relocate to his home country, Germany. Nambiar will take over as the new MD from January 31, 2015.
Read the Economic Times news report here.
